Heart failure is a growing problem, placing an increasing burden on public health resources
and continuing to exert a high toll in mortality and morbidity. Sleep disordered breathing …

Abstract Purpose of Review This paper reviews treatment options for sleep disordered
breathing (SDB) in patients with heart failure. We sought to identify therapies for SDB with …

It is increasingly recognized that sleep-disordered breathing (SDB) is a common modifiable
risk factor for cardiovascular disease with significant impact on morbidity and potentially …

Opinion statement Sleep disordered breathing (SDB) is common in heart failure patients
across the range of ejection fractions and is associated with adverse prognosis. Although …

Sleep-disordered breathing (SDB) is the most common comorbidity in patients with heart
failure (HF) and has a significant impact on quality of life, morbidity, and mortality. A number …

The relationship between CHF and SDB is likely to be bidirectional, CHF impacting on SDB
severity and vice versa. Identification of SDB in the CHF population appears to be important …

The prevalence of sleep-disordered breathing (SDB) in the general population is 2% to 4%,
1 in contrast SDB is much more common in patients with heart failure (HF), with the …

Sleep-disordered breathing (SDB) occurs in approximately 50% of patients with reduced left
ventricular ejection fraction receiving contemporary heart failure (HF) therapies. Obstructive …

Sleep disordered breathing (SDB) is a common problem with adverse cardiorespiratory,
endocrinological, and endothelial effects. Recent studies demonstrate an even higher …

Sleep-disordered breathing (SDB) has a higher prevalence in patients with heart failure than
in the general middle-aged population. Obstructive sleep apnea (OSA), one of the forms of …